GTM · ZoomInfo Technologies Inc · Stock research

Current Thesis

The leg on offer is a legacy pivot: a de-rated B2B contact-data subscription business trying to re-price as the data layer under AI go-to-market agents. On 2026-08-05 ZoomInfo beat and raised — Q2 revenue $310.4M vs $301.5M consensus, FY26 revenue guide lifted to $1.207–1.217B from $1.185–1.205B, FY26 adj EPS to $1.12–1.13 from $1.10–1.12 — and the stock moved from a $3.66 regular-session close on print day to $4.18 by 2026-08-07, roughly +14% in two sessions with RSI(14) at 76.9.

The same quarter carried a $650.5M goodwill impairment, a $622M GAAP operating loss, net revenue retention of 89% (from 90%), and revenue growth of 1.2% YoY. That combination is what dates the narrative life-cycle as DEAD: the growth story that supported the $12.20 52-week high has broken (price -65.7% from it, -34.5% over three months), management has written down the carrying value of the acquired data assets, and the sell-side answer to a beat-and-raise was two target cuts (UBS and DA Davidson to $4.50, both 2026-08-06) plus a maintained Sell at $2.50 (Citigroup, 2026-08-07). A replacement narrative exists — GTM.AI, GTM Studio, hybrid consumption pricing, GTM Bench launched 2026-07-10 — but it has not yet produced a retention or growth datapoint. What is running is a mean-reversion bounce inside a broken structure.

Bullish and bearish views on ZoomInfo Technologies Inc

The model's bull view on ZoomInfo Technologies Inc (GTM), in brief: Beat on both lines, 2026-08-05: Q2 revenue $310.4M vs $301.5M consensus; adj EPS $0.28 vs $0.27. The bear view: The raise sits on a base growing 1.2% YoY. Both cases follow in full.

Bull Case

• Beat on both lines, 2026-08-05: Q2 revenue $310.4M vs $301.5M consensus; adj EPS $0.28 vs $0.27. Adjusted operating income $110M, +5% YoY, margin 35% and up ~130bps.
• Guidance raised twice in one release: FY26 revenue $1.207–1.217B (prior $1.185–1.205B, consensus $1.195B); FY26 adj EPS $1.12–1.13 (prior $1.10–1.12, consensus $1.11); Q3 revenue $298–301M vs $293.7M consensus; Q3 adj EPS $0.28–0.29 vs $0.28.
• Cash generation is the anchor: unlevered free cash flow $107.3M in Q2, +7% YoY, at 98% conversion against adjusted operating income; FY26 unlevered FCF guided $403–423M.
• Capital returned into the drawdown: 6.3M shares repurchased in Q2 2026 at a $4.51 average — above the 2026-08-07 close — alongside $58.5M of debt principal retired; net leverage 2.3x trailing EBITDA versus 2.4x at year-end 2025.
• Mix is moving upmarket: 76% of business upmarket in Q2 2026 versus 72% in Q2 2025; customers at $100k+ ACV of 1,891, +9 YoY.
• Product surface is new, not stale: GTM Bench (2026-07-10) as an evaluation harness for LLMs and AI agents on go-to-market tasks; the DemandScience partnership (2026-07-29) bolting demand-generation onto the data asset; GTM.AI and GTM Studio introduced at the Q2 print.

Bear Case

• The raise sits on a base growing 1.2% YoY. A 2.8% revenue beat against a near-flat base is a guidance-setting artifact as much as a demand signal.
• Net revenue retention 89%, down from 90%. Below 100% means the installed base shrinks each renewal cycle before any new logo is counted.
• Down-market ACV -12% YoY, and $100k+ ACV customers fell 9 sequentially to 1,891 — the upmarket mix improved partly because the bottom eroded.
• $650.5M goodwill impairment in Q2 2026, producing a $622M GAAP operating loss, plus $35.3M of restructuring charges. Management marked the acquired asset base down in the same quarter it raised guidance.
• Balance sheet: $1.27B total debt against $150.6M cash and investments. The headline free-cash-flow metric is unlevered and excludes the $10M of cash interest paid in Q2.
• The sell-side did not follow the beat. Five notes between 2026-07-20 and 2026-08-07: Wells Fargo Underweight PT $3 (lowered), Stifel Hold $3.50 then $4 (raised 08-06), UBS Neutral $4.50 (lowered), DA Davidson Neutral $4.50 (lowered), Citigroup Sell $2.50 (raised). No Buy among them.
• Structural competition: the same agent tooling the pivot is built on makes a static contact database easier to substitute. No dated metric in the Q2 disclosure quantifies GTM.AI or consumption-pricing revenue.

Setup & Price Structure

• Last completed daily close $4.18 (2026-08-07). 52-week high $12.20; distance -65.7%. Three-month return -34.5%.
• Print-day regular-session close was $3.66 (2026-08-05), $3.81 after hours. The move to $4.18 by 08-07 is ~+14% across two sessions — a gap-and-go off the earnings shelf, with $3.66 as the pre-print reference the move originated from.
• RSI(14) at 76.9 is the observable to hold onto: a maximally stretched short-term reading in a name still two-thirds below its annual high. Overbought inside a downtrend describes a compressed spring releasing, and it says nothing about trend repair.
• Positioning and crowding observables, stated plainly. The $4.18 close sits above three of the five targets published in the prior three weeks ($2.50, $3.00, $4.00) and below the $4.50 pair. The $4.50 cluster is 7.7% above the close and coincides with the company's own $4.51 Q2 repurchase average — the price at which corporate demand was already transacting. There is no scheduled company event inside the next 30 days to refresh the bid. Insider filings reviewed for 2026 show RSU vesting and 4,598 shares withheld at $2.93 to cover tax, i.e. non-discretionary activity; that is a partial record, not a full insider census.
• The buyback is the one persistent, non-discretionary bid in the structure, and it was struck above spot last quarter.

Catalyst Calendar (next 30 days)

• 2026-08-09 → 2026-09-08: no confirmed company-scheduled event. The 30-day window is empty. Q2 (2026-08-05) is behind; the next earnings print is a quarter away. Anything that moves the tape in this window is flow, a rating change, or an unscheduled announcement.
• ~2026-09-15 (est.) — Piper Sandler Growth Frontiers Conference appearance, per conference listings; not verified against the company IR calendar at the time of writing, and 37 days out, so outside the window above.
• ~2026-11-03 (est.) — Q3 2026 print. Guided $298–301M revenue and $113–115M adjusted operating income; the checkable items are NRR against the 89% just printed and any first quantification of consumption-based pricing.

What Would Change Our Mind

The structure that matters is the earnings gap itself. Price came off a $3.66 close on 2026-08-05; a full retrace of that gap removes the only bullish price event of the last three months and leaves a name making lower highs against a $12.20 annual high. A daily close below $3.66 is the gradeable break.

On the fundamental side, two datapoints would settle it in the other direction. Net revenue retention printing below 89% at the Q3 report (~2026-11-03) would show the pivot is not slowing base erosion, and would make the FY26 revenue raise a one-quarter timing effect. A second goodwill write-down after the $650.5M taken in Q2 would say the same thing about the asset base. Conversely, a break and hold above the $4.50 area — where both the remaining Neutral targets and the company's own Q2 repurchase average sit — would be the first evidence in this leg that the tape is pricing something the sell-side has not modelled. Absent either, the ~2026-09-15 conference passing with no dated consumption-pricing or GTM.AI revenue metric leaves the pivot unquantified for another full quarter.

Correlation Notes

• Moves with the de-rated seat-based B2B software and sales-tech complex, where the shared driver is whether AI agents expand software seats or replace them. GTM sits on the side of that debate the market has been fading.
• Not correlated to the AI infrastructure trade. There is no semis, power or data-centre transmission channel here; the AI exposure is on the application-consumption side, which has been the funding source for the infrastructure bid rather than a beneficiary of it.
• Rate and small-cap-software beta run through the balance sheet: $1.27B of debt against $150.6M of cash and investments makes the equity a levered claim on the FCF guide ($403–423M unlevered, FY26).
• The DemandScience partnership (2026-07-29) ties a read-through to B2B demand-generation and marketing budgets, which have been the weakest line in enterprise software spend through this cycle.
• Ticker-level idiosyncrasy: the buyback (6.3M shares in Q2 at $4.51) is a mechanical bid that does not scale with market beta, so drawdowns can decouple from peers on the way down and lag them on the way up.